Protocol for assessment of potential risk factors for 2019-novel coronavirus (SARS-Co-V-2) infection among high risk populations in health care and emergency services settings.
A prospective clinical trial led by Drs. Grace Aldrovandi and Anne Rimoin to research the incidence and prevalence of COVID-19 among asymptomatic or minimally symptomatic (e.g. headache or allergic rhinitis symptoms) Health System Workers (HSW) at UCLA. The study is intended to provide epidemiological and serologic information which will inform the identification of risk factors for SARS-CoV-2 infection.
Learn more
